COVID-19 Vaccine Acceptability and Its Determinants in Mozambique: An Online Survey.

COVID-19 Mozambique SARS-CoV-2 online survey vaccine acceptability

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
27 Jul 2021
Historique:
received: 18 06 2021
revised: 17 07 2021
accepted: 19 07 2021
entrez: 28 8 2021
pubmed: 29 8 2021
medline: 29 8 2021
Statut: epublish

Résumé

A high worldwide SARS-CoV-2 vaccine coverage must be attained to stop the COVID-19 pandemic. In this study, we assessed the level of willingness of Mozambicans to be vaccinated against COVID-19. Data were collected between 11 and 20 March 2021, through a self-administered online survey. Of the 1878 respondents, 30.1% were healthcare workers, 58.3% were aged between 18 and 35 years, 60% were male, and 38.5% were single. Up to 43% had been tested for COVID-19 and 29% had tested positive. Overall vaccine acceptability was 71.4% (86.6% among healthcare workers, 64.8% among other respondents;

Identifiants

pubmed: 34451953
pii: vaccines9080828
doi: 10.3390/vaccines9080828
pmc: PMC8402577
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Vaccines (Basel). 2021 Jun 18;9(6):
pubmed: 34207018
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
Expert Rev Vaccines. 2021 Aug;20(8):921-933
pubmed: 34252336
Hum Vaccin Immunother. 2021 Jul 3;17(7):2279-2288
pubmed: 33522405
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Vaccine. 2021 Apr 8;39(15):2024-2034
pubmed: 33722411
Vaccines (Basel). 2021 May 07;9(5):
pubmed: 34067103
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):
pubmed: 33731429
Pan Afr Med J. 2021 Mar 02;38:230
pubmed: 34046135
Lancet. 2020 Mar 21;395(10228):922
pubmed: 32199474
Pragmat Obs Res. 2020 Oct 29;11:103-109
pubmed: 33154695
Vaccines (Basel). 2021 May 21;9(6):
pubmed: 34064159
BMC Public Health. 2021 Jun 10;21(1):1106
pubmed: 34112143
Med Princ Pract. 2021;30(3):262-271
pubmed: 33486492
Vaccines (Basel). 2021 Jan 12;9(1):
pubmed: 33445581
Vaccines (Basel). 2021 May 17;9(5):
pubmed: 34067682
J Multidiscip Healthc. 2020 Nov 20;13:1657-1663
pubmed: 33262600
JAMA. 2020 Oct 27;324(16):1601-1602
pubmed: 32910182
Vaccines (Basel). 2021 Mar 18;9(3):
pubmed: 33803730
Pragmat Obs Res. 2021 May 27;12:37-47
pubmed: 34079423
Vaccines (Basel). 2021 Feb 14;9(2):
pubmed: 33672938
Clin Exp Vaccine Res. 2021 May;10(2):183-190
pubmed: 34222131

Auteurs

Janeth Dula (J)

Health Policy and Systems Program, National Institute of Health, Maputo 1120, Mozambique.

Alexandre Mulhanga (A)

Health Policy and Systems Program, National Institute of Health, Maputo 1120, Mozambique.

Armindo Nhanombe (A)

Health Policy and Systems Program, National Institute of Health, Maputo 1120, Mozambique.

Laurentino Cumbi (L)

Health Policy and Systems Program, National Institute of Health, Maputo 1120, Mozambique.

António Júnior (A)

Health Policy and Systems Program, National Institute of Health, Maputo 1120, Mozambique.

Joe Gwatsvaira (J)

Department of Mathematics and Statistics, University of Limerick, V94 T9PX Limerick, Ireland.

Joseph Nelson Siewe Fodjo (JNS)

Global Health Institute, University of Antwerp, 2000 Antwerp, Belgium.

Edlaine Faria de Moura Villela (E)

Disease Control Coordination, São Paulo State Health Department, São Paulo 01246-000, Brazil.
Institute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia 74605-050, Brazil.

Sérgio Chicumbe (S)

Health Policy and Systems Program, National Institute of Health, Maputo 1120, Mozambique.

Robert Colebunders (R)

Global Health Institute, University of Antwerp, 2000 Antwerp, Belgium.

Classifications MeSH